When Prior Authorization Comes Before the Clinical Policy
Prior authorization requirements and clinical policies are often discussed together, but they do not always arrive at the same time. A health plan can require prior authorization for a therapy before it has published a clinical policy explaining how that request will be evaluated.
That creates a different operational problem than a restrictive policy.
The issue is not necessarily that coverage criteria are difficult to meet. It is that the coverage standard may not yet be publicly visible.
A Prior Authorization Without a Published Coverage Framework
When a payer has published a clinical policy, providers can review the criteria before submitting a request. The policy may outline diagnostic requirements, prior treatment expectations, documentation standards, or other conditions for coverage. Whether the policy is permissive or restrictive, it provides a reference point that allows providers to prepare a request around known expectations.
That framework is not always available.
New therapies, recently approved indications, and treatments for rare diseases can create situations where utilization management begins before a corresponding clinical policy has been published. Prior authorization may already be required, but the written criteria that providers expect to consult do not yet exist in a publicly available form.
The absence of a published policy does not necessarily mean the payer has no internal review process. It does mean the provider has less visibility into how that request will be evaluated.
Case Review Becomes Less Predictable
Without published criteria, the path through prior authorization becomes harder to anticipate.
Instead of comparing a patient's clinical circumstances against a documented policy, providers may need to rely more heavily on supporting literature, clinical documentation, medical necessity arguments, and the individual facts of the case. The review process can become more dependent on how the payer approaches a therapy that has not yet been incorporated into a standardized coverage framework.
Coverage may still be approved, but the basis for approval is less transparent to the provider submitting the request. That can make it more difficult to anticipate documentation needs, counsel patients about the process, or understand why one case succeeds while another does not.
Clinical Policies Provide More Than Coverage Criteria
Clinical policies are often viewed primarily as documents that define what a payer will cover. They also serve another function by making the review process more visible.
A published policy gives providers a starting point before the request is submitted. It allows clinical teams to understand the evidence the payer expects, organize documentation accordingly, and identify potential barriers before a denial occurs.
Without that reference, the prior authorization process becomes less standardized from the provider's perspective. Even if the payer applies a consistent internal review process, the absence of publicly available criteria leaves providers with less information to prepare the request.
An Operational Question Worth Tracking
As more therapies enter the market and indications continue to expand, the timing between a prior authorization requirement and the publication of a clinical policy may become increasingly important.
That leaves an operational question worth following: when prior authorization begins before a clinical policy is publicly available, how does that affect the consistency and transparency of coverage decisions until standardized criteria are published?
The Prior Auth Report launches in late July with ongoing analysis of payer behavior, workflow burden, and the operational patterns emerging underneath prior authorization transparency data. If you want structured analysis delivered directly to your inbox as this reporting landscape evolves, the newsletter waitlist is below.